MEF2D and precursor B-cell acute lymphoblastic leukemia: A genomic study by Gu et al. identified fusions between MEF2D (myocyte enhancer factor 2D) and five genes (BCL9, CSF1R, DAZAP1, HNRNPUL1, and SS18) in 22 B-ALL cases (Gu et al. 2016).